Stocktoria
Whitehawk Therapeutics, Inc. WHWK
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-06-26
Whitehawk Therapeutics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -1601.1% | -259.6% | -295.4% | -411.9% | -794.4% |
| Net margin | -288.3% | -245.1% | -270.0% | -397.7% | -786.4% |
| FCF margin | -1371.4% | -235.6% | -261.3% | -329.2% | -160.5% |
| Return on assets | -13.7% | -90.6% | -49.7% | -32.8% | -69.7% |
| Return on equity | -15.1% | -121.4% | -62.5% | -38.2% | -80.7% |
| Current ratio | 10.26 | 3.59 | 4.72 | 9.56 | 9.90 |
| Revenue growth | -72.5% | 6.7% | 60.1% | 8.7% | 0.0% |
Source: SEC EDGAR filings · CIK 0001422142 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.